2024年3月13日 · Alirocumab comes as a single-dose (1 time) pre-filled pen (autoinjector). Your healthcare provider will prescribe the dosage that is best for you. Alirocumab is injected under the skin (subcutaneously) every 2 weeks or every 4 weeks (monthly). Do not shake this medicine. Prepare an injection only when you are ready to give it.

2024年3月12日 · Praluent (alirocumab) is an injectable medicine that is given under your skin which may be used in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of chest pain conditions (unstable angina); or to treat hig

2024年7月15日 · Rotate the injection sites; To administer the 300 mg dose, give two 150 mg injections consecutively at 2 different injection sites; Administer into areas that are not tender, bruised, red, or indurated; Missed Dose: WITHIN 7 DAYS: If dose is missed within 7 days of scheduled dose, administer the missed dose and resume regular dosing schedule

2024年12月13日 · Common (1% to 10%): Injection site reaction (erythema, redness, itching, swelling, pain, tenderness) Patients who developed ADA (antidrug antibody) had a higher incidence of injection site reactions compared with patients who did not develop ADA (10.2% vs 5.9%). Musculoskeletal

2024年9月25日 · Step 8 The injection has finished when the whole window has turned completely yellow. You can now remove the pen from your skin. Step 9 Press the cotton ball against the injection site for a short period of time and then place a …

2024年12月13日 · Inject into areas of thigh, abdomen (except for 2-inch area around the navel), or upper arm that are not tender, bruised, red, or indurated; rotate injection sites. To administer a 300 mg dose of alirocumab, administer 2 consecutive doses of 150 mg at 2 different injection sites. If a dose is missed, administer as soon as remembered within 7 days.

2024年3月11日 · Sanofi and Regeneron Offer Praluent (alirocumab) at a New Reduced U.S. List Price: Apr 25, 2017: Approval Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent (alirocumab) Injection: Jul 24, 2015: Approval FDA Approves Praluent (alirocumab) to Treat Certain Patients with High Cholesterol: Jun 9, 2015

2024年9月17日 · (alirocumab) injection, for subcutaneous use: What is PRALUENT? PRALUENT is an injectable prescription medicine used: in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of chest …

2024年9月19日 · How do you administer a Praluent injection? Does Praluent (alirocumab) lower triglycerides? Drug information. Repatha (666 reviews) Praluent (303 reviews) Evolocumab (679 reviews) Alirocumab (312 reviews) Related support groups. Repatha (32 questions, 101 members) Praluent (9 questions, 45 members) Evolocumab (8 questions, 4 members) …

Praluent (alirocumab) Injection for Subcutaneous use More information please phone: 800-675-8416 Visit Website Provider: Praluent Pen Disposal Program